
GC19264
NMS-P118
Also known as 2-[1-(4,4-difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-1H-isoindole-4-carboxamide
NMS-P118 is a potent, orally available, and highly selective PARP-1 Inhibitor for cancer therapy
ChemicalCAS1262417-51-5MW395.42FormulaC20H24F3N3O2
- CAS number
- 1262417-51-5
- Molecular weight
- 395.42
- Formula
- C20H24F3N3O2
- Solubility
- DMSO : 16 mg/mL (40·46 mM)
- InChIKey
- ARYVAQSYRLZVQD-UHFFFAOYSA-N
- Catalogue number
- GC19264
- Brand
- GLPBIO
Computed properties PubChem CID 49843531 · XLogP 2.5 · TPSA 66.6 Ų · H-bond donors 1
- XLogP
- 2.5
- TPSA
- 66.6 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 3
- Heavy atoms
- 28
SMILES C1CC(CCC1N2CCC(CC2)N3CC4=C(C3=O)C(=CC(=C4)F)C(=O)N)(F)F
Computed descriptors from PubChem (CID 49843531), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il